In the UK, under-30s will be offered an alternative to the AstraZeneca vaccine after it was found to be a possible cause for blood clots.
The recommendation comes after a UK review, which found 79 people had suffered rare blood clots after vaccination - and 19 died.
Meanwhile, the EU's medicines regulator says unusual blood clots should be listed as a possible very rare side effect of the AstraZeneca jab, but that the benefits outweighed the risks.
Some European countries have restricted the vaccine's use.
Berlin correspondent Thomas Sparrow spoke to Susie Ferguson.
